Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Vx-001
i
Other names:
Vx-001, Vx001
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Vaxon Biotech
Drug class:
Tumor-associated antigen inhibitor
Related drugs:
‹
CVGBM (0)
MANA-312 (0)
MultiTAA T cell therapy (0)
Heat Shock Protein Peptide Complex-96 (0)
RAV 12 (0)
astuprotimut-R (0)
CVGBM (0)
MANA-312 (0)
MultiTAA T cell therapy (0)
Heat Shock Protein Peptide Complex-96 (0)
RAV 12 (0)
astuprotimut-R (0)
›
Associations
News
Trials
Filter by
Latest
over3years
Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in "Immune Desert" NSCLC. (PubMed, Cancers (Basel))
These results support the hypothesis that Vx-001 may be efficient in patients with non-immunogenic/cold but not with immunogenic/hot tumors.
over 3 years ago
Clinical • Journal • Tumor Mutational Burden • PD(L)-1 Biomarker • IO biomarker
|
TMB (Tumor Mutational Burden) • CD8 (cluster of differentiation 8) • GZMB (Granzyme B)
|
PD-L1 expression
|
Vx-001
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login